Moreover, a western blot analysis performed on tumour specimens to evaluate the effect of treatment on protein expression revealed that, whereas gefitinib alone was ineffective, enzastaurin was able to inhibit pAkt, pp70S6K, pGSK3β and VEGF, and the combination of the two agents caused a more efficient inhibition of the above proteins. The gene discussed is VEGFA; the disease is neoplasm.